Skip to main content

Precision Medicine: A New Approach to Cancer Treatment

Thousands of cancer patients are getting medication based on the type of genes driving their disease, not the type of cancer, in a new federal study.

Lead image for this article

Thousands of cancer patients are getting medication based on the type of genes driving their disease, not the type of cancer, in a new federal study. The approach is a departure from past practice, in which the location of cancer tumors in the patient’s body determined medication. The National Cancer Institute will launch the precision medicine experiment at more than 2,400 locations. (Business Insider)

Support public-service journalism that gets the context right

Yes, I'll donate today